NorthStar Asset Management (Pennsylvania)’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
NorthStar Asset Management (Pennsylvania)'s NVS Position: Q1 2026 in Review
NorthStar Asset Management (Pennsylvania) reduced its Novartis (NVS) stake by 0.36% in Q1 2026, selling an estimated $7.66K and leaving 13,875 shares worth $2.12M. The position accounts for 0.48% of the portfolio, ranked #46.
NorthStar Asset Management (Pennsylvania) first reported a position in NVS in Q2 2013 and has held it in 14 quarters since. The position peaked at $3.93M in Q2 2013. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- NorthStar Asset Management (Pennsylvania) held 13,875 shares of Novartis worth $2.12M as of Q1 2026.
- NorthStar Asset Management (Pennsylvania) sold 50 Novartis shares in Q1 2026, an estimated $7.66K.
- Novartis made up 0.48% of NorthStar Asset Management (Pennsylvania)'s portfolio in Q1 2026, its #46 holding.
- NorthStar Asset Management (Pennsylvania) first reported a position in Novartis in Q2 2013 and has held it in 14 quarters since.
- NorthStar Asset Management (Pennsylvania)'s Novartis position peaked at $3.93M in Q2 2013.
- 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on NorthStar Asset Management (Pennsylvania)'s 13F filing for Q1 2026, filed 23 Apr 2026.